Literature DB >> 27241923

Salvage surgery in patients with recurrent or residual squamous cell carcinoma of the anus.

Y Alamri1, P Buchwald1, L Dixon1, B Dobbs1, T Eglinton1, J McCormick1, C Wakeman1, F A Frizelle2.   

Abstract

INTRODUCTION: Anal squamous cell cancers are uncommon, and primary treatment is radical chemoradiotherapy. The role of radical surgery is in salvage of patients with residual and recurrent disease. The primary aim of the study is to determine how often such salvage surgery is required, while the secondary aim is to determine which features indicate salvage surgery may be required and to determine the outcome of salvage surgery.
METHODS: A prospective database was analysed of all patients with anal cancer over an 18 year period (Dec 1996-Jan 2015). The records of patients requiring salvage surgery were reviewed.
RESULTS: 203 Patients were identified with anal cancers, of which 180 had squamous cell anal carcinoma. 112 Female (median age 59.4, range 33-92) 68 male (median age 63.8 range 36-87). Of these 27 patients (15%) required salvage surgery. 23 Patients had a R0 resection. 18 Patients had an extended resection (16 R0) while 9 had a routine APR (7 R0). The 30-day post-operative mortality rate was 0%. The overall 5 year survival was 78%, not significantly different from those not requiring salvage surgery (p = 0.23). Age, gender, AJCC stage, T stage, radiation therapy alone, were not predicators of the need for salvage surgery.
CONCLUSIONS: Salvage surgery is uncommonly required. Extended surgery beyond routine APR is often required to obtain an R0 resection. Excellent patient survival can be achieved in highly selected cases. There were no identifiable clinical predictors of those needing salvage surgery, and consideration should be given to explore molecular and genetic factors.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anal cancer; Extended surgery outcomes; Salvage surgery

Mesh:

Year:  2016        PMID: 27241923     DOI: 10.1016/j.ejso.2016.05.006

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  3 in total

1.  Long-term results achieved by guideline-based stage-dependent management of anal cancer in a non-HIV population.

Authors:  Bernhard Fankhaenel; Joerg Zimmer; Dorothea Bleyl; Eric Puffer; Andreas Schreiber; Thomas Kittner; Helmut Witzigmann; Sigmar Stelzner
Journal:  Int J Colorectal Dis       Date:  2019-10-22       Impact factor: 2.571

2.  Immune Checkpoint Blockade in Lower Gastrointestinal Cancers: A Systematic Review.

Authors:  K C Wilson; M P Flood; D Oh; N Calvin; M Michael; R G Ramsay; A G Heriot
Journal:  Ann Surg Oncol       Date:  2021-05-28       Impact factor: 5.344

3.  Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience.

Authors:  J A W Hagemans; S E Blinde; J J Nuyttens; W G Morshuis; M A M Mureau; J Rothbarth; C Verhoef; J W A Burger
Journal:  Ann Surg Oncol       Date:  2018-04-24       Impact factor: 5.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.